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SHORT COMMUNICATION
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Imaging Patterns of Encephalopathy in Patients with
COVID-19
Kumail Khandwala, Fatima Mubarak and Muhammad Nadeem Ahmad
Department of Radiology, The Aga Khan University Hospital, Karachi, Pakistan
ABSTRACT
The aim of this retrospective observational study was to describe the neuroimaging manifestations of patients with COVID-19.
This study was conducted at Aga Khan University Hospital, Karachi, Pakistan from March to July 2020. COVID-19 patients with
neurological symptoms and positive neuroimaging were included after confirmation of COVID-19 by polymerase chain reaction
test (PCR). In the 12 included patients, seizures and altered mentation were predominant neurological manifestations. Three
cases had acute watershed infarcts (25%), two cases had posterior cerebral artery territorial infarcts (16.7%), two cases had
periventricular corona radiata infarcts (16.7%), three cases had hypoxic ischemic encephalopathy (25%), two cases had poste-
rior reversible encephalopathy syndrome (16.7%), and there was one case each of cerebral venous sinus thrombosis, pontine
infarct, and bithalamic lesions (8.3%). This study highlights the diagnostic approaches in COVID-19-associated encephalopathy
and the variable imaging features that clinicians and neuroradiologists should be aware of, as the pandemic progresses. 
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Coronavirus disease (COVID-19) originated in December 2019 in
Wuhan, China, probably from an animal source, and has since
then had a rapid rate of transmission to the rest of the world, and
being declared a global pandemic by the World Health Organisa-
tion. The typical symptoms of COVID-19 are respiratory-related.
The elderly, especially those with comorbid conditions, are more
likely to develop critical illness resulting in high mortality rates in
this age group.
COVID-19 has characteristic laboratory findings and lung radio-
graphic  and  computed  tomography  (CT)  abnormalities.
However, neuroimaging features in COVID-19 patients have not
been widely documented as yet. According to the available litera-
ture, patients with COVID-19 infection can present with acute
encephalopathy with changes in their level of consciousness,
acute stroke, as a result of thromboembolic phenomena and/or
seizures.1
In this study, the authors report cases of COVID-19 patients, who
presented with neurological manifestations, and describe their
relevant  neuroimaging  features.  To  date,  these  are  the  first
reported cases of COVID-19 from the subcontinent with positive
findings on neuroimaging.
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This was a retrospective-descriptive study commenced after
approval was obtained from the Ethical Review Committee. Pa-
tients with COVID-19, who presented with neurological symp-
toms to the Aga Khan University Hospital,  Karachi,  Pakistan
from March 2020 to July 2020, were included after they had
neuroimaging  done  from  the  Radiology  Department  of  this
hospital.  Severe  acute  respiratory  syndrome  coronavirus  2
(SARS-CoV-2) infection was confirmed by quantitative RT-PCR
by  nasopharyngeal  or  oropharyngeal  swab.  Patient  demo-
graphic data, comorbid conditions, neurological symptoms and
relevant investigations (laboratory and neurophysiology) were
retrieved from the electronic records of the patients. Patients
who had negative imaging findings were excluded.
Data entry and analyses were carried out on Microsoft Excel.
Quantitative demographic data were reported as mean ± stan-
dard  deviation.  The  qualitative  data  was  expressed  as
frequency (percentage).
A total of 12 patients with SARS-CoV-2 infection met the inclu-
sion criteria and had neurological involvement with positive
imaging findings. There were two pediatric patients. The mean
age was 48.1 ± 28.3 years (range, 0.5-81). A summary of the
demographic  data,  clinical  and  neuroimaging  features  are
provided in Table I. Neurological symptoms included seizures
and altered mentation (n = 5), drowsiness (n = 4), encephalo-
pathy (n = 3), acute loss of consciousness (n = 2), motor weak-
ness (n = 3), and headache and anosmia (n = 1). Neurological
symptoms were part of the initial presentation in four patients
(33.3%).
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Table I: Summary of patient demographic details, comorbidities, clinical presentation and neuroimaging findings.
Patient demographics &
comorbidities Neurological clinical presentation Neuroimaging findings
6 month old male, VSD and PDA GTC, moderate encephalopathy Bilateral acute internal watershed territory infarcts with PRESand microhemorrhages
3 year old female, NKCM GTC, altered mentation, quadriparesis Bithalamic non-diffusion restricted lesions
29 year old male, NKCM Anosmia, GTC, headache, mildencephalopathy
Cerebral venous sinus thrombosis with hemorrhagic venous
infarct
35 year old male, NKCM Acute loss of consciousness Global hypoxic ischemic encephalopathy
38 year old female, SLE and
hypothyroidism
GTC and altered mentation, severe
encephalopathy
PRES, holohemispheric encephalopathy without diffusion
restriction
41 year old male, NKCM Drowsiness, altered mentation Global hypoxic ischemic encephalopathy and multifocalmicrohemorrhages
56 year old male, NKCM GTC Global hypoxic ischemic encephalopathy/postictal
68 year old female, DM, HTN and
asthma Drowsiness and altered mentation
Right posterior cerebral artery acute infarct with hemorrhagic
conversion
72 year old female, CLD Acute loss of consciousness Small acute infarct in left corona radiata
75-year old male, DM, CHD Drowsiness and new onset left sidedperipheral motor weakness
Subacute infarction in the right posterior cerebral artery
territory with hemorrhagic conversion
79-year-old female, DM, HTN Drowsiness and altered mentation Bilateral internal watershed infarcts, pontine infarct
81 year old male, chronic atrial
fibrillation and asthma
Drowsiness and new onset left sided
hemiparesis
Left internal watershed infarcts, left occipital lobe,
periventricular corona radiata
VSD: Ventricular septal defect, PDA: Patent ductus arteriosus, GTC: Generalised tonic seizures, PRES: Posterior reversible encephalopathy syndrome,
NKCM: No known comorbidities, SLE: Systemic lupus erythematosus, DM: Diabetes mellitus, HTN: Hypertension, CHD: Congestive heart disease
Figure 1: (A&B) Coronal FLAIR images of a 38-year female, showing
hyperintense signals in the parieto-occipital white matter and bilat-
eral centrum semiovale, suggestive of PRES and a holohemispheric
pattern of encephalopathy (arrows). These signals did not show diffu-
sion restriction. (C) Axial DWI B-value 1000 image showing diffusion
restriction  in  the  basal  ganglia  and  posterior  parieto-occipital
cortices of a 41 year old male suggestive of hypoxic ischemic injury.
(D) Multifocal susceptibility dropout in the same patient, indicative
of microhemorrhages.
Systemic  manifestations  included  fever  (n = 7),  dyspnea
(n = 4), cough (n = 3), and hypernatremic dehydration (n =
1). Five patients (41.7%) had no known comorbidities. Elec-
troencephalography  showed  mild,  moderate  and  severe
encephalopathy in the three out of four patients tested. One
patient  had  continuous  epileptiform  discharges  with
myoclonic  jerks  and  was  subsequently  diagnosed  with
postictal encephalopathy on imaging. Eight patients (66.7%)
showed raised D-dimer levels (above the normal reference
values).
Neuroimaging  revealed  three  cases  with  acute  diffusion
restricted  internal  border  zone  watershed  infarcts  (25%),
and two cases with acute and subacute right sided posterior
cerebral artery territorial infarcts with areas of hemorrhagic
conversion  (16.7%).  There  were  three  cases  of  hypoxic
ischemic  encephalopathy  (25%),  two  cases  of  posterior
reversible encephalopathy syndrome (16.7%), two cases of
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multiple microhemorrhages (16.7%) two cases of periventric-
ular corona radiata infarcts (16.7%), and one case each of
cerebral venous sinus thrombosis, pontine infarct, and non-
diffusion restricted bi-thalamic lesions (8.3%, Figures 1 and 2).
Figure 2: (A) Axial T2 weighted sequence showing bilateral parieto-oc-
cipital  hyperintensities,  suggestive  of  PRES,  with  splenial  signal
abnormality in a 6-month boy with COVID-19. (B) Axial DWI in the
same  patient  showing  bilateral  diffusion  restricted  internal  water-
shed territory infarcts. (C&D) Axial T2 and coronal FLAIR in a 3-year
girl with bithalamic signal abnormalities extending to the cerebral
peduncles. These were not diffusion restricted or showing any hemor-
rhage.
SARS-COV-2  may enter the central nervous system (CNS)
through the hematogenous or retrograde neuronal route, as
seen with other respiratory viruses. The latter is advocated
by the fact that some patients had experienced anosmia,
including  one  patient  in  this  series.  The  data  regarding
COVID-19  neurological  manifestations  and  neuroimaging
features is scarce.1 This study demonstrated that the neuroi-
maging features of COVID-19 patients were variable. Acute
ischemic  infarcts  and  different  patterns  of  encephalopathy
were predominant  in  these patients.  The encephalopathy
spectrum  in  this  series  included  posterior  reversible
encephalopathy syndrome (PRES), global hypoxic-ischemic
encephalopathy, and cortical and deep grey matter pattern
of T2 FLAIR hyperintense signal with associated restriction
diffusion  that  may  be  caused  by  hypoxic/ischemic  or  post-
ictal  effects.  This  has  also  been  similarly  reported  by
Mahammedi  et  al.2
Bilateral  frontotemporal  hypoperfusion has been noted in
patients who underwent perfusion imaging in a prior study.3
It was, however, found that the patterns of encephalopathy
encountered predominantly involving the posterior circula-
tion and watershed areas, suggesting that these areas are
prone to hypoperfusion and are therefore more vulnerable in
this disease. Both cases of acute territorial infarction in this
study involved the posterior cerebral artery territory, with
areas of hemorrhagic conversions, also indicating that these
are the more likely arterial territories to be affected. A plau-
sible  explanation  may  be  deficient  adrenergic  sympathetic
innervations  in  the  vertebrobasilar  system  than  in  the
carotid  system.  A  proposition  for  increased  incidence  of
stroke and thromboembolic phenomena in COVID-19 may
also be cytokine storm syndrome, related to the prothrom-
botic effect of the inflammatory response.4
Two patients had multifocal microhemorrhages; one patient
with extensive cerebral venous sinus thrombosis involving
the  superior  sagittal  sinus,  right  transverse  and  sigmoid
sinuses had a large hemorrhagic venous infarct in the right
frontal lobe. There was one patient with spontaneous intrac-
erebral hemorrhage and cerebral venous sinus thrombosis
each in the study from Wuhan, China, as well.1 It has been
hypothesised that  brain angiotensin converting enzyme II
could be involved in COVID-19 infection; and its dysfunction,
leading to disruption of cerebral autoregulation and hemor-
rhage, due to arterial wall rupture.5
This study also included two pediatric cases, one of whom
had watershed ischemic insults with PRES and microhemor-
rhages, and the other had bithalamic non-diffusion restricted
lesions without any hemorrhage or enhancement. Interest-
ingly,  the  first  reported  case  of  COVID-19–associated  acute
necrotising  hemorrhagic  encephalopathy  showed  involve-
ment of bilateral thalami. These types of bithalamic abnor-
malities have also been noted in other viral encephalitides.
Signal  abnormality  was  seen  in  the  splenium  of  corpus
callosum of the pediatric patient with watershed infarcts and
PRES. This is similar to a recent study in which acute splenial
lesions were noted in all four pediatric cases with COVID-19
related encephalopathies.6 The changes are thought to be
attributable  to  focal  intramyelinic  edema  secondary  to
inflammation,  but  may  also  be  seen  in  other  types  of  viral
illnesses. 
Regarding meningoencephalitis, none of our cases showed
abnormal parenchymal or leptomeningeal enhancement. A
study done in  France showed a  high  incidence of  lepto-
meningeal enhancement, predominantly in occipital lobe in
8 out of their 13 patients.3 Some authors, however, propose
that CSF titers of the virus may be extremely low and dissem-
ination is usually transient.
The key limitations of this study are the small sample size
and single-centre experience. Additionally, it could not be
determined  whether  these  findings  were  coincidental  or
specific to COVID-19 infection. Further studies are warranted
to validate the pathogenesis and mechanism of neurological
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involvement in this multisystemic viral syndrome. However,
neurologists and neuroradiologists should be aware of the
wide  spectrum of  neuroimaging  patterns  associated  with
COVID-19, as this pandemic progresses. Overall, this article
indicates that the CNS may be variably involved in COVID-19
and  highlights  the  diagnostic  approaches  to  SARS-CoV-2
associated encephalopathy.
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